HV

Clinical trials for HV explained in plain language.

Never miss a new study

Get alerted when new HV trials appear

Sign up with your email to follow new studies for HV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug BW-41012 enters first human safety tests

Knowledge-focused Recruiting now

This early-phase trial will test the safety and tolerability of a single injection of BW-41012 in 40 healthy adults aged 18 to 65. Participants will be randomly assigned to receive either the drug or a placebo, and researchers will monitor for side effects and measure how the dru…

Matched conditions: HV

Phase: PHASE1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated Jul 11, 2026 00:00 UTC

HV

Get alerted when new HV trials appear

New drug BW-41012 enters first human safety tests